Take the poll: what price will Juno's IPO open for trading??
Thursday, 11-December-2014
Juno Therapeutics is shaping up to be biotech's most anticipated, and largest IPO of 2014. In a regulatory filing with the SEC, the initial terms of the deal were set on Tuesday. They plan to offer 9,250,000 shares at a price range of $15-$18. The underwriters have an option to sell an additional 1,387,500 shares. Note: these terms might change
At the high end of the range, and presuming the underwriters sell their extra shares, this would bring in approximately $191 million, and gives the company a market capitalization of about $1.4 billion. There will be 77,553,606 shares of common stock outstanding afterwards.
So let's have some fun with the BIG question at hand: where do you think the stock will open for trading? Please cast your vote below, and I will tweet out the results at the end of the day.
UPDATE: Voting is now closed and the results are in. Thanks to all of those who participated!
Who Am I?
I'm an individual investor from Kansas City. My focus is on biotech stocks, but I enjoy investing in all industries. I'm an old-school, buy and hold investor who believes the best way to outperform and grow capital is to own innovative companies with good management teams over the long-term. more>>